Treatment challenges and investigational opportunities in autoimmune hepatitis
Albert J. Czaja(Mayo Clinic in Arizona), Mikio Zeniya(International University of Health and Welfare), Herschel A. Carpenter(Mayo Clinic in Arizona), Ansgar W. Lohse(Universität Hamburg), Diego Vergani(King's College - North Carolina), Francesco B. Bianchi, Ian G. McFarlane, Gotaro Toda, Michael P. Manns(Medizinische Hochschule Hannover), Edward L. Krawitt(University of Vermont), Giorgina Mieli‐Vergani(King's College London)
Cited by 94
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
|Hepatology|2019|903
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631